Gaps Driving Fraud, Patient Harm, and FCA Liability

Disclaimer: The views expressed in this article are my personal opinions and do not reflect the views or policies of any affiliated organization. This article is intended for informational purposes only and should not be construed as anything else.

Like Cicero denouncing corruption in the Roman Senate, today’s boards and executives face hidden governance and quality gaps that threaten patients, public funds, and legal compliance.

Healthcare organizations that work with state and federal programs are legally required to maintain effective compliance and quality systems. Underfunding these systems is not just a budgeting decision—it is a governance failure. Boards and executives have a fiduciary and oversight duty to appropriate resource compliance and quality programs. Failing to do so exposes organizations to violations of fraud, waste, abuse, and mismanagement regulations and can lead to liability under the False Claims Act.

Compliance and quality departments have historically been underfinanced compared to the complexity of their responsibilities. As regulatory demands have grown, budgets often remain flat or shrink in real terms. Under-resourced programs create gaps in oversight, allowing errors in billing, coding, documentation, and quality reporting to go undetected. These gaps increase the risk of CMS audits, funding penalties, legal exposure, and patient harm when quality issues are not promptly addressed. Guidance from CMS and the Office of Inspector General emphasizes that compliance and quality systems must be adequately staffed, monitored, and documented to meet federal program requirements.

Whistleblower protections exist to safeguard employees or contractors who report underfunding or systemic compliance failures. Reports under the Healthcare Whistleblower Protection Act or the False Claims Act may trigger investigations and enforcement actions. Federal law protects whistleblowers from retaliation. Boards can be held accountable when compliance and quality failures result from willful neglect or gross mismanagement, with potential consequences including civil penalties, reputational damage, and heightened regulatory scrutiny.

Industry guidance suggests that compliance and quality programs in healthcare organizations are commonly funded at one to five percent of total revenue, depending on the organization’s size, risk profile, and regulatory complexity. This is a baseline, not a target. Boards are expected to fund these programs sufficiently to enable timely detection, reporting, and remediation of risks. Financial support for compliance and quality functions is not optional; it is a governance requirement. Properly funded programs protect public dollars, support patient safety, and reduce exposure to regulatory and legal action.

Boards must recognize that underfunding compliance and quality systems carries real consequences. Ensuring these programs are effective is an essential part of governance and a key mechanism to prevent financial, legal, and human harm. Adequate resources are not simply operational—they are a core responsibility of leadership and oversight. Guidance from CMS and OIG makes it clear that failure to provide sufficient resources can constitute a breach of fiduciary duty, putting the organization and its leadership at risk.

Join the conversation—also posted on LinkedIn: https://www.linkedin.com/pulse/healthcare-boards-executives-risk-governance-quality-gaps-raphael-px69e